Rituximab with standard LMB chemotherapy in pediatric high-risk mature B-cell non-Hodgkin lymphoma: A report from the JPLSG B-NHL14 trial.
Tetsuya MoriTomoo OsumiAkiko KadaKentaro OhkiYuhki KogaReiji FukanoNaoto FujitaTetsuo MitsuiTakeshi MoriAkiko M SaitoAtsuko NakazawaRyoji KobayashiMasahiro SekimizuPublished in: European journal of haematology (2023)
The efficacy and safety of rituximab in combination with LMB chemotherapy in children with high-risk mature B-NHL was observed in Japan.